[恶性血液系统疾病中的血液疗法]
[Hemotherapy in malignant hematologic diseases].
作者信息
Marti H R
出版信息
Schweiz Med Wochenschr. 1975 Jun 14;105(24):778-9.
PMID:49923
Abstract
For the majority of patients with malignant blood diseases the ideal transfusion products are blood components instead of whole blood. The therapeutic use of packed red cells, platelets, leukocytes and albumin is briefly discussed.
摘要
对于大多数恶性血液病患者而言，理想的输血产品是血液成分而非全血。本文简要讨论了浓缩红细胞、血小板、白细胞和白蛋白的治疗用途。
相似文献
1
[Hemotherapy in malignant hematologic diseases].
Schweiz Med Wochenschr. 1975 Jun 14;105(24):778-9.
2
[Specific hemotherapy].
Internist (Berl). 1969 Feb;10(2):52-8.
3
[Current possibilities for optimal hemotherapy].
Z Prakt Anasth. 1971 Aug;6(4):263-76.
4
[Experiences at the Blood Transfusion Center of the Socialist Republic of Serbia in providing aimed transfusions].
Bilt Hematol Transfuz. 1975;3(1-2):11-9.
5
[The therapeutic use of stored blood and blood substitutes indications and contraindications].
Wiad Lek. 1969 Jan 1;22(1):19-24.
6
TRANSFUSION OF BLOOD FRACTIONS.
Practitioner. 1965 Aug;195:193-200.
7
[Hemotherapy "made to measure", or, selective use of blood and blood components].
Infusionstherapie (1973). 1974 Aug;1(6):425-31.
8
Use of blood components in clinical practice. Blood components.
N Y State J Med. 1971 Jun 15;71(12):1518-22.
9
Blood and blood products replacement therapy.
J Reprod Med. 1977 Oct;19(4):233-40.
10
[PRACTICAL IDEAS ON BLOOD TRANSFUSION].
Gaz Med Fr. 1964 Apr 10;71:1317-24.
Zotero 插件